US Patent Issued to SIRNAOMICS on April 14 for "SiRNA compound that inhibits complement factor B (CFB)" (Maryland Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,967, issued on April 14, was assigned to SIRNAOMICS INC. (Gaithersburg, Md.).

"SiRNA compound that inhibits complement factor B (CFB)" was invented by Dmitry Samarsky (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Nucleic acid products that modulate, in particular interfere with or inhibit CFB gene expression, are provided. The products may be oligomeric compounds that comprise at least a first region of linked nucleosides having at least a first nucleobase sequence that is at least partially complementary to at least a portion o 5 f RNA transcribed from a CFB gene, where the first nucleobase sequence is selected from SEQ ID NOs ...